Pasithea Therapeutics Growth Metrics (2021-2024) | KTTA

Growth Metrics Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Growth Ratios
EBITDA Margin Growth (1y) 1.75M1.89M
EBITDA Margin (QoQ) -0.84M1.78M0.01M0.80M-0.70M
EBIT Margin Growth (1y) 2.30M1.81M
EBIT Margin (QoQ) -0.16M1.75M0.01M0.71M-0.65M
EBT Margin Growth (1y) 1.70M1.51M
EBT Margin (QoQ) -0.46M1.42M0.02M0.72M-0.65M
Enterprise Value Growth (1y) -106.16%37.53%40.55%44.16%53.55%50.64%59.85%70.12%52.47%
Enterprise Value Growth (3y) 23.08%
Enterprise Value (QoQ) -157.55%4.99%4.73%11.56%21.96%9.59%10.51%26.43%17.08%26.46%33.39%-17.01%
FCF Margin Growth (1y) 2.12M1.34M
FCF Margin (QoQ) 0.15M1.22M0.08M0.68M-0.63M
Gross Margin (QoQ) -0.00M0.01M0.00M
Interest Coverage Ratio (QoQ) 106.50%
Net Margin Growth (1y) 0.28M0.34M
Net Margin (QoQ) -0.11M0.33M-0.03M0.09M-0.05M
Operating Margin Growth (1y) 2.30M1.81M
Operating Margin (QoQ) -0.16M1.75M0.01M0.71M-0.65M
Return on Assets Growth (1y) 1.00-1.00-1.00-3.003.00-12.00-34.00-55.00
Return on Assets (QoQ) 2.000.00M2.00-4.000.00M0.00M0.00M3.00-15.00-22.00-21.00
Return on Capital Employed Growth (1y) -16.00-21.00-23.00-24.00-34.00-44.00-51.00-46.00
Return on Capital Employed (QoQ) 0.00M-4.00-6.00-7.00-5.00-6.00-7.00-16.00-15.00-14.00-1.00
Return on Equity Growth (1y) 1.00-2.00-2.00-4.003.00-13.00-38.00-59.00
Return on Equity (QoQ) 3.001.002.00-4.000.00M0.00M0.00M3.00-17.00-24.00-20.00
Return on Sales Growth (1y) 0.00M0.00M-103.00285.00-0.00M
Return on Sales (QoQ) -0.00M0.00M-261.00898.00-503.00-236.00126.00-0.00M